References
1) Oakley AM, Krishnamurthy K. Stevens Johnson Syndrome.
In: StatPearls . Treasure Island (FL): StatPearls Publishing;
April 19, 2021.
2) Su SC, Chung WH. Update on pathobiology in Stevens-Johnson syndrome
and toxic epidermal necrolysis. Dermatologica Sinica. 2013;31(4), 175–180. doi:10.1016/j.dsi.2013.09.002.
3) Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson
syndrome. Orphanet J Rare Dis . 2010;5:39. Published 2010 Dec 16.
doi:10.1186/1750-1172-5-39.
4) Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of
COVID-19: A Systematic Review. Adv Wound Care (New Rochelle) .
2021;10(2):51-80. doi:10.1089/wound.2020.1309
5) Parlakay A, Ozcan S, Karaatmaca B, Tiftik M. COVID-19 presenting like
Steven Johnson Syndrome in a pediatric patient. Authorea . 2020
doi: 10.22541/au.159286119.92728253.
6) Bulat V, Likic R, Pondeljak N, Azdajic MD. Pholcodine-induced
Stevens-Johnson syndrome in a patient with COVID-19 [published online
ahead of print, 2021 Apr 20]. Postgrad Med J .
2021;postgradmedj-2021-139892. doi:10.1136/postgradmedj-2021-139892